Venkateswarlu
Venkateswarlu Basyam, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20150256432 | MANAGING RESOURCES IN A NETWORKED COMPUTING ENVIRONMENT - An approach for managing and optimizing available resources utilized in a networked computing environment (e.g., a cloud computing environment) is provided. In one aspect, a plurality of resources in a plurality of storage pools within the networked computing environment are monitored. Each storage pool is running at least one application workload using a corresponding subset of the plurality of resources. The storage pools are ranked based on the application workloads. In response to an over-utilized storage pool and/or an under-utilized storage pool, the plurality of resources are dynamically reconfigured. | 09-10-2015 |
Venkateswarlu Bhamidi, Kingsport, TN US
Patent application number | Description | Published |
---|---|---|
20160060196 | CRYSTALLIZED HYDROQUINONE AND METHODS OF MAKING - Crystallized hydroquinone particles and methods for making the same are provided. Cooling profiles applied during crystallization of the hydroquinone from solution may be optimized to provide crystallized particles having suitable properties and that exhibit reduced agglomeration tendencies, even after long periods of time and/or transportation over long distances. | 03-03-2016 |
Venkateswarlu Chamcha, Atlanta, GA US
Patent application number | Description | Published |
---|---|---|
20150231228 | HIV IMMUNE STIMULATING COMPOSITIONS COMPRISING RECOMBINANTLY EXPRESSED PILI ON BACTERIA AND METHODS RELATED THERETO - This disclosure relates to recombinant bacteria, e.g. | 08-20-2015 |
Venkateswarlu Karicheti, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20110236318 | ANIMAL MODEL OF AN EJACULATION-LIKE REFLEX - An animal model of an ejaculation-like reflex, wherein the ejaculation-like reflex is induced by continuous infusion of saline through a catheter extending into the proximal urethra of a non-human male animal, and wherein the urethra of the animal is occluded by extending and bending the penis at the base; and a method of screening a test substance for effectiveness in prevention or treatment of male ejaculatory dysfunction using the animal model. | 09-29-2011 |
Venkateswarlu Karnati, Guntur IN
Patent application number | Description | Published |
---|---|---|
20110182497 | CASCADE STRUCTURE FOR CLASSIFYING OBJECTS IN AN IMAGE - A cascade object classification structure for classifying one or more objects in an image is provided. The cascade object classification structure includes a plurality of nodes arranged in one or more layers. Each layer includes at least one parent node and each subsequent layer includes at least two child nodes. A parent node in a layer is operatively linked to two child nodes in a subsequent layer. Further, at least one child node in one of the subsequent layers is operatively linked to two or more parent nodes in a preceding layer. Each node includes classifiers for classifying the objects as a positive object and a negative object. The positive object and the negative object classified by the parent node in each layer are further classified by one or more operatively linked child nodes in the subsequent layer. | 07-28-2011 |
Venkateswarlu Katepalli, Birmingham GB
Patent application number | Description | Published |
---|---|---|
20120202482 | Generating Measurement Reports Under Rapid Degradation of Radio Conditions - A user equipment (UE), comprising at least one component configured to support a handover during decreasing radio conditions, wherein an event is triggered using at least one of a time to trigger for rapid degradation or radio conditions (TTTrd) value and a filter coefficient for rapid degradation of radio conditions (FCrd) value that are different than the corresponding standard values indicated by a network. Also included is a UE, comprising at least one component configured to support a method comprising obtaining cell measurements using network indicated standard parameters and parameters configured for rapid degradation of radio conditions, monitoring radio conditions, and evaluating an event using the parameters configured for rapid degradation of radio conditions if rapid degradation of radio conditions is detected, or using the network indicated standard parameters otherwise. | 08-09-2012 |
Venkateswarlu Kondragunta, Woburn, MA US
Patent application number | Description | Published |
---|---|---|
20100028893 | METHODS AND COMPOSITIONS FOR PHARMACOGENETIC ANALYSIS OF ANTI-INFLAMMATORY DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS AND OTHER INFLAMMATORY DISEASES - The invention provides methods and compositions for the pharmacogenetic analysis of anti-inflammatory compounds, especially for the pharmacogenetic association of responsiveness to rheumatoid arthritis medications that target TNFα. | 02-04-2010 |
20100112570 | Genetic Markers for Weight Management and Methods of Use Thereof - This application relates to methods and tests that allow for the establishment of personalized weight-loss programs for a subject based upon the subject's metabolic genotype in key metabolic genes. Kits and methods are disclosed for determining a subject's metabolic genotype, which may be used to select an appropriate therapeutic/dietary regimen or lifestyle recommendation based upon the likelihood of a subject's responsiveness to certain diets and activity levels. Such a personalized weight-loss program will have obvious benefits (e.g., yield better results in terms of weight loss and weight maintenance) over traditional weight-loss programs that do not take into account genetic information. | 05-06-2010 |
20100255475 | DIAGNOSTICS AND THERAPEUTICS FOR OSTEOPOROSIS - Diagnostics and therapeutics for osteoporosis, which are bases upon the identification of a subjects IL-1 haplotype and genotype pattern are described. | 10-07-2010 |
20110008906 | Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss - Diagnostics and therapeutics for resistance to weight-loss, which are based upon the identification of a subject's PLIN polymorphisms, haplotype and genotype pattern, are described in this invention. | 01-13-2011 |
20130011841 | Genetic Association of Polymorphisms in Perilipin (PLIN) Gene With Resistance to Weight Loss - Diagnostics and therapeutics for resistance to weight-loss, which are based upon the identification of a subject's PLIN polymorphisms, haplotype and genotype pattern, are described in this invention. | 01-10-2013 |
Venkateswarlu Kondragunta, Fishers, IN US
Patent application number | Description | Published |
---|---|---|
20120115137 | Methods of Predicting Osteoarthritis - The present invention relates generally to methods for predicting progression, initiation and susceptibility of osteoarthritis in human subjects using their genotype test results. | 05-10-2012 |
Venkateswarlu Muvva, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20100292473 | PROCESS FOR PREPARING (2R,3S/2S,3R)-2-(2,4-DIFLUOROPHENYL)-3-(5-FLUOROPYRIMIDIN-4-YL)-1-(1H-1,2- ,4-TRIAZOL-1-YL)BUTAN-2-OL - Voriconazole is prepared by a process comprising condensing 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazole-1-yl)ethanone with 4-chloro-6-ethyl-5-fluoropyrimidine, in a ketone, ether, aliphatic hydrocarbon, or aromatic hydrocarbon solvent, to give (2R,3S/2S,3R)-3-(4-chloro-5-fluoropyrimidin-6-yl)-2-(2,4-diflurophenyl)-1-(1H-1,2,4-triazole-1-yl)butan-2-ol. | 11-18-2010 |
20140357863 | PROCESS FOR PREPARATION OF PURE LINAGLIPTIN - The present application provides a process for preparation of Linagliptin reacting (R)-piperidine-3-amine of Formula II or an acid addition salt thereof with 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine of Formula III in the presence of a suitable base in an inert organic solvent. | 12-04-2014 |
Venkateswarlu Talapaneni, Cupertino, CA US
Patent application number | Description | Published |
---|---|---|
20120087374 | CONTEXT-SWITCHED MULTI-STREAM PIPELINED REORDER ENGINE - A pipelined reorder engine reorders data items received over a network on a per-source basis. Context memories correspond to each of the possible sources. The pipeline includes a plurality of pipeline stages that together simultaneously operate on the data items. The context memories are operatively coupled to the pipeline stages and store information relating to a state of reordering for each of the sources. The pipeline stages read from and update the context memories based on the source of the data item being processed. | 04-12-2012 |
Venkateswarlu Tallapaneni, Andhra Pradesh IN
Patent application number | Description | Published |
---|---|---|
20100324265 | PROCESS FOR THE PREPARATION GLATIRAMER ACETATE (COPOLYMER-1) - This invention relates to a convenient and improved process for preparation of glatiramer acetate (copolymer-1) of pharmaceutical grade. The process involves polymerizing N-carboxyanhydrides of tyrosine, alanine, y-benzyl glutamate and &egr;-N-trifluoroacetyllysine in dioxane with diethylamine as initiator to afford protected copolymer-1. Treatment with hydrogen bromide in acetic acid at 35° C. for 3-5 h cleaves benzyl group to produce trifluoroacetyl copolymer-1. The trifluoroacetyl copolymer-1 is washed with an organic solvent to remove reactive benzyl bromide generated during debenzylation. Deprotection with aqueous piperidine, followed by dialysis offers glatiramer acetate (copolymer-1) of Molecular weight 5000-9000 daltons. | 12-23-2010 |
Venkateswarlu Upputuri, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090327533 | Concatenating Secure Digital Input Output (SDIO) Interface - An apparatus and a process for transferring packet data includes receiving packets from a first interface such as a network interface and transferring data to a second interface such as an SD Bus interface such as SDIO using a protocol such as one described in SDCard.org. The SD Bus second interface operates as a slave device to a master device, and the packet transfer from first interface to second interface includes concatenating length fields and packet data fields from packets received on the first interface to form a superframe which is provided to the second interface at time of data transfer. The formation of each superframe includes starting a timer such that the superframe is transmitted to the second interface by asserting an interrupt on that interface when either the timer expires, the number of packet from the first interface exceeds a threshold, or the amount of data from the first interface exceeds a threshold. | 12-31-2009 |
Venkateswarlu Vobalaboina, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20080226742 | Compositions for Drug Delivery - Substantially non-porous polymeric microparticles comprising a hydrophobic polymer and a plasticizer, and containing therein a bioactive or bioinactive agent. | 09-18-2008 |
20120041029 | COMPOSITIONS FOR DRUG DELIVERY - Substantially non-porous polymeric microparticles comprising a hydrophobic polymer and a plasticizer, and containing therein a bioactive or bioinactive agent. | 02-16-2012 |
20120058194 | PHARMACEUTICAL FORMULATIONS COMPRISING SUBSTITUTED BENZIMIDAZOLE DERIVATIVES - Stabilized substituted benzimidazole modified release pharmaceutical formulations with at least two drug-containing fractions, wherein the release from a first fraction precedes the release from a second fraction, pharmaceutical excipients, processes for preparing the stable formulations, packaging therefor, and their use in treatment of erosive esophagitis and heartburn associated with non-erosive gastroesophageal reflux disease. | 03-08-2012 |
20120087986 | PHARMACEUTICAL FORMULATIONS COMPRISING DESVENLAFAXINE - Pharmaceutical formulations comprising desvenlafaxine, processes for preparing formulations comprising desvenlafaxine, and therapeutic uses and methods of treatment employing formulations comprising desvenlafaxine. | 04-12-2012 |
20130236544 | STABLE PHARMACEUTICAL COMPOSITIONS OF FESOTERODINE - The present invention relates to stable pharmaceutical compositions comprising fesoterodine or a pharmaceutically acceptable salt thereof. In particular, the invention relates to pharmaceutical compositions of fesoterodine or a pharmaceutically acceptable salt thereof and a stabilizer. The invention also relates to processes for making such compositions and the methods of using such compositions. | 09-12-2013 |
Venkateswarlu Vobalaboina, Warangal IN
Patent application number | Description | Published |
---|---|---|
20140051733 | FEBUXOSTAT PHARMACEUTICAL COMPOSITIONS - The present application discloses stable pharmaceutical compositions for the oral administration of febuxostat with pharmaceutical excipients which provide improved dissolution rate and polymorphic stability both while manufacturing and during storage and process for preparing the stable compositions, packaging and their use in the treatment of gout of hyperuricemia. | 02-20-2014 |